Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210029973 210009265 0 85 Palliative (P) 2015-10-24 2015-11-02 UKALL14- Ph 2 Induction + Imatinib Y N 210018243 UKALL2014
210029974 210009268 1.75 84.4 Curative (C) 2015-01-24 2015-03-10 UKALL14- Maintenance Y null 210018253 UKALL2014
210029975 210009271 1.84 82 Curative (C) 2015-06-07 2015-08-28 UKALL 14 TRIAL N N 210018261 UKALL2014
210029976 210009273 1.93 84.4 Curative (C) 2015-05-13 2015-10-25 UKALL 14 TRIAL 1 N 210018264 UKALL2014
210029977 210030790 1.83 74.5 Neo-adjuvant (N) 2014-06-30 2014-06-30 UKALL14- Maintenance 02 Y 210018266 UKALL2014
210029978 210019877 1.71 66.9 Curative (C) 2014-01-08 2014-07-03 UKALL 14 TRIAL N N 210018273 UKALL2014
210029979 210009279 1.75 108.55 Curative (C) 2015-02-23 2015-02-23 UKALL14- Cons Cycle 3 01 N 210018276 UKALL2014
210029980 210019879 1.73 50.7 Palliative (P) 2015-11-21 2015-11-21 UKALL14- Maintenance Y N 210018278 UKALL2014
210029981 210009285 1.57 74 Curative (C) 2017-08-06 2017-08-06 UKALL14- Ph 2 Induction Y null 210018281 UKALL2014
210029982 210009287 1.73 96.6 Curative (C) 2017-08-04 2017-09-04 UKALL14- Maintenance 02 N 210018288 UKALL2014
210029984 210009293 null 52.7 Curative (C) 2017-02-11 2017-03-27 UKALL14- Maintenance 02 N 210018303 UKALL2014
210029985 210019887 1.82 null Curative (C) 2014-08-21 2015-01-08 UKALL14- Ph 2 Induction 01 N 210018316 UKALL2014
210029986 210009296 1.77 82.5 Curative (C) 2017-10-27 2017-11-24 UKALL14- Cons Cycle 1 1 null 210018321 UKALL2014
210029987 210009300 1.94 78.8 Curative (C) 2016-05-16 2016-09-24 UKALL 14 TRIAL N N 210018324 UKALL2014
210029988 210009302 1.75 74.6 Curative (C) 2018-01-14 2018-01-22 UKALL14- Ph 2 Induction 02 N 210018334 UKALL2014
210029989 210019894 1.77 91.5 Adjuvant (A) 2013-07-30 2013-08-05 UKALL14- Cons Cycle 2 N Y 210018336 UKALL2014
210029990 210009307 1.67 92 Palliative (P) 2018-05-08 2018-10-03 UKALL14- Intens/CNS Proph 02 N 210018337 UKALL2014
210029992 210009310 1.88 97.6 Disease modification (D) 2014-03-29 2014-08-09 UKALL14- Maintenance Y N 210018343 UKALL2014
210029993 210009311 1.67 79 Palliative (P) 2013-06-02 2013-07-10 UKALL14- Maintenance 01 N 210018353 UKALL2014
210029994 210009317 1.75 106.3 Curative (C) 2016-05-18 2016-05-18 UKALL14- Maintenance N N 210018363 UKALL2014
210029996 210009321 null 87.3 Curative (C) 2014-10-29 2014-10-30 UKALL14- Cons Cycle 2 Y null 210018371 UKALL2014
210029997 210019903 null 80.7 Curative (C) 2013-06-30 2013-08-06 UKALL14- Maintenance + Imatinib 2 N 210018378 UKALL2014
210029998 210009324 1.65 82.5 Curative (C) 2017-09-24 2017-10-28 UKALL14- Ph 2 Induction N null 210018380 UKALL2014
210029999 210009328 1.79 78 Curative (C) 2018-03-01 2018-03-01 UKALL14- Intens/CNS Proph Y N 210018384 UKALL2014
210030000 210009329 null 114 Curative (C) null 2016-07-13 UKALL14- Maintenance Y N 210018385 UKALL2014
210030001 210009331 1.85 83.2 Curative (C) null 2015-12-01 UKALL14- Intens/CNS Proph Y null 210018399 UKALL2014
210030002 210009333 1.64 52.7 Disease modification (D) 2015-01-02 2015-01-15 UKALL14- Maintenance 2 null 210018405 UKALL2014
210030003 210009335 null null Curative (C) 2017-01-19 2017-01-28 UKALL14- Cons Cycle 3 N null 210018405 UKALL2014
210030004 210019912 1.76 null Curative (C) 2015-02-01 2015-06-08 UKALL14- Intens/CNS Proph N N 210018415 UKALL2014
210030005 210009338 1.82 79.9 Curative (C) 2013-08-22 2013-10-04 UKALL14- Ph 2 Induction + Imatinib Y null 210018415 UKALL2014
210030006 210019914 1.74 null Curative (C) null 2014-02-24 UKALL14- Maintenance + Imatinib N N 210018417 UKALL2014
210030007 210009341 1.78 92 Adjuvant (A) null 2012-12-09 UKALL 14 TRIAL 2 N 210018421 UKALL2014
210030008 210009341 null 64 Curative (C) 2013-11-03 2013-11-07 UKALL14- Ph 1 Induction 02 N 210018421 UKALL2014
210030009 210009342 1.75 65.1 Curative (C) 2014-01-05 2014-02-16 UKALL14- Cons Cycle 3 null N 210018435 UKALL2014
210030010 210009345 null 94.2 Curative (C) 2013-09-02 2013-09-02 UKALL14- Maintenance 02 null 210018446 UKALL2014
210030011 210009346 1.71 74 Palliative (P) 2016-04-20 2016-04-20 UKALL14- Maintenance + Imatinib N null 210018447 UKALL2014
210030012 210009347 1.72 60.2 Adjuvant (A) 2016-06-13 2016-10-17 UKALL14- Maintenance N N 210018450 UKALL2014
210030013 210009350 1.69 91.8 Curative (C) 2015-01-16 2015-01-16 UKALL14- Intens/CNS Proph +Imatinib 01 N 210018451 UKALL2014
210030014 210009354 0 78 Palliative (P) 2013-12-10 2013-12-21 UKALL14- Intens/CNS Proph 02 N 210018458 UKALL2014
210030015 210019927 1.68 72.6 Disease modification (D) 2014-12-28 2014-12-28 UKALL14- Maintenance 1 N 210018466 UKALL2014
210030016 210009359 1.84 90.7 Curative (C) 2015-09-24 2015-12-21 UKALL14- Ph 1 Induction + Imatinib Y null 210018475 UKALL2014
210030017 210009361 1.77 115 null 2017-11-10 2017-12-08 UKALL14- Intens/CNS Proph +Imatinib N N 210018484 UKALL2014
210030018 210026750 1.64 84.6 Curative (C) 2014-03-10 2014-03-17 UKALL14- FMC (2 day) Conditioning N null 210018489 UKALL2014
210030019 210009366 1.65 53 Curative (C) 2017-05-22 2017-07-04 UKALL14- Maintenance N N 210018494 UKALL2014
210030021 210009375 1.62 69.7 Adjuvant (A) 2017-12-13 2017-12-25 UKALL14- Ph 2 Induction Y N 210018518 UKALL2014
210030022 210009379 1.71 143.8 Curative (C) 2017-11-05 2017-11-07 UKALL14- Ph 2 Induction + Imatinib 1 N 210018537 UKALL2014
210030023 210009381 1.82 null Curative (C) 2013-07-20 2013-10-17 UKALL14- Cons Cycle 1 + Imatinib 02 N 210018538 UKALL2014
210030024 210009382 1.68 61 Curative (C) null 2015-09-08 UKALL14- Maintenance + Imatinib N Y 210018556 UKALL2014
210030025 210009384 1.77 67.1 Disease modification (D) 2017-08-06 2017-08-14 UKALL14- Intens/CNS Proph +Imatinib N N 210018557 UKALL2014
210030026 210009387 1.77 91.5 Curative (C) 2015-08-11 2016-01-19 UKALL14- Ph 2 Induction + Imatinib N N 210018559 UKALL2014